Read More 1 minute read Analyst Ratings News Price Target Upgrades Daiwa Capital Upgrades Merck & Co to Outperform, Raises Price Target to $102 By Benzinga Newsdesk July 7, 5:55 AM Daiwa Capital analyst Narumi Nakagiri upgrades Merck & Co (NYSE:MRK) from Hold to Outperform and raises the price target from $89 to $102. MRK
Read More 1 minute read News Rumors Tech Report Twitter is Working on in-app Podcast Player By Charles Gross July 7, 5:52 AM https://twitter.com/wongmjane/status/1544981108823310336 SPOT
Read More 1 minute read Analyst Ratings Initiation News Price Target Needham Initiates Coverage On Duolingo with Buy Rating, Announces Price Target of $115 By Benzinga Newsdesk July 7, 5:50 AM Needham analyst Ryan MacDonald initiates coverage on Duolingo (NASDAQ:DUOL) with a Buy rating and announces Price Target of $115. DUOL
Read More 1 minute read Analyst Ratings News Price Target Upgrades RBC Capital Upgrades Cerence to Sector Perform, Lowers Price Target to $27 By Benzinga Newsdesk July 7, 5:47 AM RBC Capital analyst Joseph Spak upgrades Cerence (NASDAQ:CRNC) from Underperform to Sector Perform and lowers the price target from $28 to $27. CRNC
Read More 1 minute read Analyst Ratings Initiation News Price Target Needham Initiates Coverage On GitLab with Buy Rating, Announces Price Target of $70 By Benzinga Newsdesk July 7, 5:44 AM Needham analyst Mike Cikos initiates coverage on GitLab (NASDAQ:GTLB) with a Buy rating and announces Price Target of $70. GTLB
Read More 1 minute read News Tech Meta Plans to Call New Virtual Reality Headset the ‘Quest Pro’ By Charles Gross July 7, 5:42 AM -Bloomberg https://www.bloomberg.com/news/articles/2022-07-06/meta-plans-to-call-new-virtual-reality-headset-the-quest-pro META
Read More 1 minute read Analyst Ratings Initiation News Price Target Chardan Capital Initiates Coverage On EyePoint Pharmaceuticals with Buy Rating, Announces Price Target of $21 By Benzinga Newsdesk July 7, 5:39 AM Chardan Capital analyst Daniil Gataulin initiates coverage on EyePoint Pharmaceuticals (NASDAQ:EYPT) with a Buy rating and announces Price Target of $21. EYPT
Read More 1 minute read Analyst Ratings Downgrades News Price Target Citigroup Downgrades Consolidated Comms Hldgs to Sell, Announces $5 Price Target By Benzinga Newsdesk July 7, 5:25 AM Citigroup analyst Michael Rollins downgrades Consolidated Comms Hldgs (NASDAQ:CNSL) from Neutral to Sell and announces $5 price target. CNSL
Read More 1 minute read Analyst Ratings Initiation News Price Target Mizuho Initiates Coverage On BioXcel Therapeutics with Buy Rating, Announces Price Target of $19 By Benzinga Newsdesk July 7, 5:19 AM Mizuho analyst Graig Suvannavejh initiates coverage on BioXcel Therapeutics (NASDAQ:BTAI) with a Buy rating and announces Price Target of $19. BTAI
Read More 1 minute read News At Least Three Probable Cases of Monkeypox Have Been Identified in San Francisco By Charles Gross July 7, 5:18 AM -KPIX 5 https://www.cbsnews.com/sanfrancisco/news/monkeypox-sfdph-officials-identify-3-additional-cases/ AEMD